Product Images Novolin 70/30

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 34 images provide visual information about the product associated with Novolin 70/30 NDC 0169-3007 by Novo Nordisk, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Novolin 70/30 Vial Carton - image 01

Novolin 70/30 Vial Carton - image 01

Novolin 70/30 Relion Vial Carton - image 02

Novolin 70/30 Relion Vial Carton - image 02

Novolin is a brand of insulin injections that contains a combination of human insulin isophane suspension and human insulin injection. The provided packaging comes in U-100, with an NDC code of 0160-1837-11. It is advised to be used with U-100 insulin and to keep under medical supervision, stored in a refrigerator. It is manufactured by Novo Nordisk and comes in the Novolin B 70/30 formulation. Contact information for the manufacturer is also included.*

image 03

image 03

Novolin® W70/30 is a type of human insulin medication that comes in an isophane suspension form. The medication is designed to be used with U-100 insulin and should be injected carefully. It is recommended to store the medication in a refrigerator below 77°F. For more information, contact the medical supplier mentioned on the packaging.*

image 04

image 04

This is a product description for a medication called GRS. The text includes dosage information and a warning to administer cautiously, as well as a list of other medications. It also includes a patent information and contact details for the drug manufacturer, Novo Nordisk. However, there is some garbled text which is unreadable and makes it difficult to understand the full context.*

image 05

image 05

This is a description of the Novolin 70/30 FlexPen, a medication injection used in treating diabetes. The text gives information about its chemical properties, dosage amounts, and instructions on proper usage. It also includes a warning to be cautious when administering the medicine and to follow proper technique. The medication contains phenol and metscsol 35 Shrenaine, and is not recommended for individuals with specific allergies or medical conditions. The text also mentions patent information and the manufacturer, Novo Nordik.*

image 12

image 12

image 13

image 13

image 14

image 14

NovoFine, NovoFine Plus, and NovoTwist are names of medical products, possibly needles or syringe attachments. "Bigouer" and "Bigower" are unclear and could be misspellings. The text also includes references to "4p stk Pty," "4p ootk Pt," and "@333" which are not readily discernible. The phrase "0% o Y S A" is also unclear and appears to be incomplete. The final line mentions a "needlecap" and a company or brand called "Nasdh Brotetis s". Overall, the text is difficult to interpret and provide a useful description.*

image 15

image 15

image 16

image 16

image 17

image 17

image 18

image 18

image 19

image 19

image 20

image 20

image 21

image 21

image 22

image 22

image 23

image 23

image 24

image 24

image 25

image 25

image 26

image 26

image 27

image 27

image 28

image 28

image 29

image 29

image 30

image 30

image 31

image 31

image 32

image 32

image 33

image 33

image 34

image 34

image 35

image 35

image 36

image 36

image 37

image 37

image 38

image 38

image 39

image 39

image 40

image 40

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.